![Thomas J. Tarlow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas J. Tarlow
Consejero General en Talon Therapeutics, Inc. .
Cargos activos de Thomas J. Tarlow
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Consejero General | 01/01/2009 | - |
Historial de carrera de Thomas J. Tarlow
Antiguos cargos conocidos de Thomas J. Tarlow.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Consejero General | - | - |
Formación de Thomas J. Tarlow.
University of California, Davis | Graduate Degree |
University of California, Santa Cruz | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
General Counsel | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas J. Tarlow
- Experiencia